Bioline Rx Ltd Price/Book
What is the Price/Book of Bioline Rx Ltd?
The Price/Book of Bioline Rx Ltd is 0.37
What is the definition of Price/Book?
Price to book ratio represents the ratio between a company’s stock value and the book value per share.
mrq (most recent quarter)
The price to book ratio, or P/B ratio, is a financial ratio used to compare a company's current market price to its book value. It is also sometimes known as a market to book ratio or price to equity ratio. The calculation of a price to book ratio can be performed in two ways. It can be calculated as the company's market capitalization divided by the company's total book value from its balance sheet. It can also be calculated using per-share values and dividing a company's current share price by the book value per share (i.e. its book value divided by the number of outstanding shares).
The P/B ratio varies between industries. The industries that require more infrastructure capital (for each dollar of profit) will usually trade at P/B ratios much lower than, for example, consulting firms. P/B ratios are commonly used to compare banks, because most assets and liabilities of banks are constantly valued at market values. A higher P/B ratio implies that investors expect management to create more value from a given set of assets, all else equal (and/or that the market value of the firm's assets is significantly higher than their accounting value).
P/B ratios do not, however, directly provide any information on the ability of the firm to generate profits or cash for shareholders. This ratio also gives some idea of whether an investor is paying too much for what would be left if the company went bankrupt immediately. For companies in distress, the book value is usually calculated without the intangible assets that would have no resale value. In such cases, P/B should also be calculated on a "diluted" basis, because stock options may well vest on sale of the company or change of control or firing of management.
Price/Book of companies in the Health Care sector on NASDAQ compared to Bioline Rx Ltd
What does Bioline Rx Ltd do?
biolinerx is a clinical-stage, publicly-traded (nasdaq/ tase: blrx) biopharmaceutical development company based in modi'in, israel. this website or social media page (the “site”) of biolinerx ltd. (the “company”) may contain content posted by a third party or links to third party websites (the “content” or “third party content”). this content is provided solely for general informational purposes as a convenience to you and not as an endorsement by the company of the content. it does not constitute a recommendation or solicitation to purchase or sell any security or make any other type of investment or investment decision. the company is not responsible for this content and does not make any representations as to the subject matter, accuracy, completeness or timeliness or the content. if you decide to access linked third party websites, you do so at your own risk. there is no warranty of any kind, express or implied, regarding the content, including without limitation any warranty of m
Companies with price/book similar to Bioline Rx Ltd
- Accentis N.V has Price/Book of 0.37
- Mitchells & Butlers Plc has Price/Book of 0.37
- Wanda Hotel Development has Price/Book of 0.37
- Founders Metals has Price/Book of 0.37
- Sadbhav Engineering has Price/Book of 0.37
- Palash Securities has Price/Book of 0.37
- Bioline Rx Ltd has Price/Book of 0.37
- China Yuchai International has Price/Book of 0.37
- Gran Colombia Gold has Price/Book of 0.37
- Yuk Wing has Price/Book of 0.37
- Globe Life has Price/Book of 0.37
- BlackRock Muni California Quality Fund Inc has Price/Book of 0.37
- Alternative Liquidity Fund has Price/Book of 0.37